Harbin Pharmaceutical Group Co., Ltd.

SHSE:600664 Stock Report

Market Cap: CN¥9.9b

Harbin Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 600664?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,595,5000.0634%
Institutions120,650,1074.79%
General Public1,171,388,82846.5%
Private Companies1,224,875,44148.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 53.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
46.6%
Harbin Pharmaceutical Group Holding Co., Ltd.
1,173,237,023CN¥4.6b0%no data
2.21%
China Securities Investor Protection Fund Corporation Limited, Asset Management Arm
55,725,125CN¥219.6m0%50.44%
0.95%
Zhejiang Financial Development Company
23,883,418CN¥94.1m0%no data
0.87%
First State Cinda Fund Management Company Limited
22,002,390CN¥86.7m10,800%0.2%
0.64%
Shanghai Urban Construction (Group) Corporation
16,055,000CN¥63.3m0%no data
0.53%
Bosera Asset Management Co., Ltd.
13,422,100CN¥52.9m174%0.03%
0.46%
Harbin Tianxiang Weiye Investment Co., Ltd.
11,700,000CN¥46.1m0%no data
0.3%
Fullgoal Fund Management Co. Ltd.
7,580,653CN¥29.9m0%0.01%
0.26%
The Vanguard Group, Inc.
6,504,168CN¥25.6m0%no data
0.19%
China International Capital Corporation Hong Kong Asset Management Limited
4,861,136CN¥19.2m0%0.1%
0.16%
Dimensional Fund Advisors LP
3,918,109CN¥15.4m0.12%no data
0.047%
Gfund Management Co., Ltd.
1,194,600CN¥4.7m0%0.02%
0.033%
Guotai Asset Management Company Limited
838,000CN¥3.3m0%no data
0.032%
GF Fund Management Co., Ltd.
817,600CN¥3.2m0%no data
0.026%
SWS MU Fund Management Co., Ltd.
660,100CN¥2.6m0%0.01%
0.023%
Nanhua Fund Management Co., Ltd.
584,300CN¥2.3m0%0.19%
0.02%
Bo Liu
495,100CN¥2.0m0%no data
0.014%
Chen Liang
355,000CN¥1.4m0%no data
0.013%
Zhong Ou Fund Management Co., Ltd
329,900CN¥1.3m0%no data
0.013%
Xiaodong Meng
325,400CN¥1.3m0%no data
0.012%
Harvest Fund Management Co. Ltd.
297,300CN¥1.2m0%no data
0.011%
Hongde Fund Management Co., Ltd.
279,900CN¥1.1m0%no data
0.0099%
Guoren Lin
250,000CN¥985.3k0%no data
0.0099%
Zhejiang Zheshang Securities Asset Management Co., Ltd.
249,900CN¥984.4k0%0.08%
0.0081%
Penghua Fund Management Co., Ltd.
204,900CN¥807.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:26
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Harbin Pharmaceutical Group Co., Ltd. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xing Qiu LinAJ Securities Co., Ltd
Ling Bo TuChina Minzu Securities
Wayne HeChina Stock Investment Research Co. Ltd. (GZ500..com)